Clopidogrel in infants with systemic-to-pulmonary-artery shunts

New England Journal of Medicine

Volumn 368, Issue 25, 2013, Pages 2377-2384

  Wessel, David L ^a   Berger, Felix ^b   Li, Jennifer S ^d   Daḧnert, Ingo ^c   Rakhit, Amit ^e   Fontecave, Sylvie ^f   Newburger, Jane W ^g,h  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f SANOFI   (France)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ARTICLE; BLEEDING; CARDIOVASCULAR PROCEDURE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART TRANSPLANTATION; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SHUNT THROMBOSIS; SYSTEMIC PULMONARY SHUNT; THROMBOSIS;

EID: 84879069861     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1114588     Document Type: Article

References (19)

1. Dastgiri S, Gilmour WH, Stone DH. Survival of children born with congenital anomalies. Arch Dis Child 2003;88:391-4. (Pubitemid 36566720)
2. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011;8:50-60.
3. Sano S, Ishino K, Kado H, et al. Outcome of right ventricle-to-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome: a multi-institutional study. Ann Thorac Surg 2004;78:1951-7.
4. Azakie T, Merklinger SL, McCrindle BW, et al. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg 2001;72:1349-53. (Pubitemid 32938034)
5. Yuan SM, Shinfeld A, Raanani E. The Blalock-Taussig shunt. J Card Surg 2009;24:101-8.
6. Li JS, Yow E, Berezny KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation 2007;116:293-7. (Pubitemid 47196565)
7. Al Jubair KA, Al Fagih MR, Al Jarallah AS, et al. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young 1998;8:486-90. (Pubitemid 128681584)
8. Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg 2005;79:2072-6. (Pubitemid 40804189)
9. Fenton KN, Siewers RD, Rebovich B, Pigula FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 2003;76:152-6. (Pubitemid 36819733)
10. Squizzato A, Keller T, Romualdi E, Middeldorp S. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev 2011;1:CD005158.
11. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, writing on behalf of the 2005 Writing Committee. Circulation 2008;117:261-95. [Erratum, Circulation 2008;117(6):e161.]
12. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. [Errata, N Engl J Med 2001;345:1506, 1716.] (Pubitemid 32758501)
13. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20. [Erratum, JAMA 2003;289:987.] (Pubitemid 35340537)
14. Gentilomo C, Huang YS, Raffini L. Significant increase in clopidogrel use across U.S. children's hospitals. Pediatr Cardiol 2011;32:167-75.
15. Mertens L, Eyskens B, Boshoff D, Gewillig M. Safety and efficacy of clopidogrel in children with heart disease. J Pediatr 2008;153:61-4.
16. Schidlow DN, Anderson JB, Klitzner TS, et al. Variation in interstage outpatient care after the Norwood procedure: a report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative. Congenit Heart Dis 2011;6:98-107.
17. Israels SJ, Michelson AD. Antiplatelet therapy in children. Thromb Res 2006;118:75-83.
18. Li JS, Yow E, Berezny KY, et al. Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 2008;117:553-9.
19. Jennings LK, Michelson AD, Jacoski MV, et al. Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response. Platelets 2012;23:430-8.